To complement the PLF recovery analysis, we also assessed motor neuron regeneration and reinnervation via nerve stimulation and analysis of muscle performance in vivo.
By incorporating the impact factor(IF) and Eigenfactor™(EF) into our analysis we also assessed the relationship between these indices and the output under study.
As a sensitivity analysis we also assessed the effect of excluding those assumed to be diet misreporters.
In a secondary analysis we also assessed the influence of having 'active renal disease' during follow-up.
To validate the automated nuclear shape analysis, we also assessed nuclear morphology using the standard technique: manual blind counting.
As a sensitivity analysis, we also assessed Medicaid recipients' total health expenditures (not just those paid by Medicaid) as a function of living with a smoker.
As a secondary analysis we also assessed the cost-effectiveness of screening if compliance were exactly as observed in the other countries, even in underscreened women.
In sensitivity analysis, we also assessed 4 alternate secondary strategies to determine whether the ICER for celecoxib versus an nsNSAID would remain below $60,000 per QALY for other possible postevent treatment regimens.
As a sensitivity analysis, we also assessed the avoidable waste after applying all possible adjustments (that is, adjustments considered by the expert panel as easy, moderately easy, or difficult), whatever their cost.
As a sensitivity analysis, we also assessed the use of an alternative measure of comorbidity called the Elixhauser index that was derived to predict mortality during the inpatient stay.
